AgraFlora Awarded Health Canada Research License

- December 10th, 2019

AgraFlora received a cannabis research licence, giving it the ability to develop cannabis-infused beverages at its facility in Toronto.

AgraFlora Organics International (CSE:AGRA,OTCPK:AGFAF) has been awarded a cannabis research licence from Health Canada, giving the company the ability to develop cannabis-infused beverage formulations at its GMP bottling facility in Toronto, Ontario.

As quoted in the press release:

In anticipation of the Research Licence, AgraFlora began comprehensive retrofit initiatives at the Toronto Bottling Facility including the completion of a cannabis research laboratory (the “Research Laboratory”) within its current GMP-certified premises. The Research Laboratory consists of state-of-the-art equipment for weighing, handling and processing microdosages of CBD and THC compounds, including magnetic mixers, homogenizers and high-pressure liquid chromatograph (“HPLC”).

The Company plans to immediately commence cannabinoid-related research and development activities, including:

  • Establishment of extraction protocols to isolate specific desirable compounds, including CBD, THC and THCV;
  • Cannabinoid extract infusion analysis relating to formulation and pilot batching;
  • Identification of process and physiochemical product attributes paired with analytically guided optimization;
  • Development of optimized blend formulations for water solubility and shelf stability ratios/forms;
  • High-pressure homogenization to produce superfine emulsions from cannabis oil; and,
  • Centrifugal partition chromatography to develop compounds in a powdered format.

Click here to read the full press release.

Find out what experts are saying about the future of cannabis edibles

 
Read our new report on the 2019 Lift Cannabis Business Conference
 

Get the latest Cannabis Investing stock information

Leave a Reply